The prognosis can be improved when combined with chemotherapy, especially in cancer with high PD-L1 expression, i.e., the PFS for the combined group was significantly longer than for the chemotherapy group, (with a hazard ratio of 0.69, even though the OS was not significantly different) [214]. The gene discussed is CD274; the disease is cancer.